Quantcast
Last updated on April 24, 2014 at 11:50 EDT

Latest Idiopathic pulmonary fibrosis Stories

2014-04-21 00:20:49

SAN DIEGO, April 21, 2014 /PRNewswire/ -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, and collaborators Drs. Martin Kolb and Kjetil Ask at McMaster University announced today additional measured advantages of inhaled GP-101 (aerosol pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF). Our results indicate that very small inhaled doses deliver oral-superior, but short-lived lung levels. To understand if this increased lung dose may...

2014-03-27 12:30:22

CHICAGO, March 27, 2014 /PRNewswire-USNewswire/ -- Patients with pulmonary fibrosis (PF), their caregivers, family members, and health care providers will now be able to access a centralized communications center. Established by the Pulmonary Fibrosis Foundation (PFF), the leading pulmonary fibrosis patient advocacy organization, the PFF Patient Communication Center (PCC) will be the first-ever comprehensive communication resource that will be available to the PF community. This...

2014-02-26 12:24:18

Julie Halston, Lindsay Mendez, Lucas Steele, Christina Bianco, Tony Yazbeck, Liz Callaway, Robert Creighton, Cady Huffman and Rashidra Scott join Emmy and Golden Globe nominated actor Tony Danza at the Fourth Annual Broadway Belts for PFF! NEW YORK, Feb. 26, 2014 /PRNewswire-USNewswire/ -- For the fourth consecutive year Broadway's best vocal talent appeared Monday night to raise funds for the rare disease, pulmonary fibrosis (PF), and honor the memory of Associated Press theater...

2014-02-25 08:31:00

- Study Meets Primary and Both Key Secondary Endpoints - BRISBANE, Calif., Feb. 25, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that top-line data from ASCEND, a Phase 3 trial evaluating pirfenidone in patients with idiopathic pulmonary fibrosis (IPF), demonstrated that pirfenidone significantly reduced IPF disease progression as measured by change in percent predicted forced vital capacity (FVC) from Baseline to Week 52 (rank ANCOVA p<0.000001)....

2014-02-04 16:28:20

Chief Medical Officer and Chairman of the Steering Committee for the PFF Care Center Network and PFF Patient Registry Announced CHICAGO, Feb. 4, 2014 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) today announced two key additions to their staff. Gregory P. Cosgrove, MD, has been named Chief Medical Officer and Kevin R. Flaherty, MD, MS, has been named Chairman of the Steering Committee of the PFF Care Center Network and PFF Patient Registry. "We are pleased to...

2014-01-30 12:28:26

Unique academic-industry partnership will include an IPF patient registry and biomarker bank RIDGEFIELD, Conn. and DURHAM, N.C., Jan. 30, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Duke Clinical Research Institute (DCRI) have formed a unique collaborative relationship to uncover insights into idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. As part of the partnership, Boehringer Ingelheim and Duke Clinical Research Institute will...

2014-01-09 08:27:20

- Q4'13 revenue of $25.6 million represents ninth consecutive quarter of Esbriet growth - BRISBANE, Calif., Jan. 9, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced unaudited revenue for the fourth quarter and year ended December 31, 2013. The company also provided updated 2013 expense guidance, highlighted recent progress in its commercial and other business activities and provided forward-looking guidance for 2014 revenue and expenses. (Logo:...

2014-01-06 08:26:36

BRISBANE, Calif., Jan. 6, 2014 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the 32nd Annual J. P. Morgan Healthcare Conference in San Francisco on January 13, 2014, at 12:00 Noon EST / 9:00 a.m. PST. (Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO) To access a live audio webcast of the presentation, investors and other interested parties may log on to the...

2013-12-17 12:26:27

PFF Summit 2013: An Environment to Improve Education, Facilitate Research, and Increase Disease Awareness CHICAGO, Dec. 17, 2013 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) presented its second biennial healthcare conference, PFF Summit 2013: From Bench to Bedside, in La Jolla, California, from December 5-7, 2013. The innovative conference brought together medical professionals, patients, and caregivers for a three-day meeting. Over 520 people, including...

2013-12-10 08:30:34

- Largest multi-center registry in world to advance understanding of pulmonary fibrosis - BRISBANE, Calif., Dec. 10, 2013 /PRNewswire/ -- InterMune (NASDAQ: ITMN) today announced its support of the Pulmonary Fibrosis Foundation, a leading patient advocacy organization dedicated to advancing care for people with pulmonary fibrosis worldwide, to establish the Pulmonary Fibrosis Foundation Care Center Network and Patient Registry. The Care Center Network will launch in 2014 with nine...